Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

[1]  R. Lockey,et al.  Allergens and Allergen Immunotherapy , 2008 .

[2]  S. Durham,et al.  Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis * , 2005, Allergy.

[3]  S. Durham,et al.  Prevalence and rate of diagnosis of allergic rhinitis in Europe , 2004, European Respiratory Journal.

[4]  A. Linneberg,et al.  Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system. , 2004, Clinical biochemistry.

[5]  S. Burastero,et al.  Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. , 2004, The Journal of allergy and clinical immunology.

[6]  P. O'Byrne,et al.  Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. , 2004, The American journal of medicine.

[7]  G. Canonica,et al.  Noninjection routes for immunotherapy. , 2003, The Journal of allergy and clinical immunology.

[8]  H. Malling.  Is sublingual immunotherapy clinically effective? , 2002, Current opinion in allergy and clinical immunology.

[9]  Erkka Valovirta,et al.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.

[10]  P. Cauwenberge.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2002 .

[11]  L. Jacobsen.  Preventive aspects of immunotherapy: prevention for children at risk of developing asthma. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  H. Løwenstein,et al.  MANUFACTURING AND STANDARDIZING ALLERGEN VACCINES , 2000, Radiologic Clinics of North America.

[13]  G. Passalacqua,et al.  Post‐marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients , 1999, Allergy.

[14]  S. Durham,et al.  Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.

[15]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[16]  S. Durham,et al.  Immunologic changes associated with allergen immunotherapy. , 1998, The Journal of allergy and clinical immunology.

[17]  Davis,et al.  Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  H. Løwenstein,et al.  Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long‐term (6‐year) follow‐up , 1997, Allergy.

[19]  C. Martínez-Cócera,et al.  A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy , 1996, Allergy.

[20]  M. Jacobson,et al.  Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study , 1995, Allergy.

[21]  R. Valenta,et al.  Complementary DNA cloning of the major allergen Phl p I from timothy grass (Phleum pratense); recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species. , 1994, The Journal of allergy and clinical immunology.

[22]  R. Marfisi,et al.  Rush immunotherapy with sublingual administration of grass allergen extract. , 1993, Allergologia et immunopathologia.

[23]  S. Durham,et al.  Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. , 1991, BMJ.

[24]  G. Guyatt,et al.  Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  H. Mosbech,et al.  Does the effect of immunotherapy last after termination of treatment? , 1988, Allergy.

[26]  R. Einarsson,et al.  In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice , 1988, Allergy.

[27]  O. ØSterballe,et al.  IgG Subclass Antibody Response in Grass Pollen‐Allergic Patients Undergoing Specific Immunotherapy , 1984, Allergy.